⌘K

Login Start Free

Home/Filings/4/0001883850-24-000043

4//SEC Filing

Pitofsky Jason 4

Accession 0001883850-24-000043

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:40 PM ET

Size

8.8 KB

Accession

0001883850-24-000043

Insider Transaction Report

Form 4

Period: 2024-08-07

REGENERON PHARMACEUTICALS, INC.REGN

VP Controller

Transactions

Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-08-07−487→ 0 total
Exercise: $372.46Exp: 2029-12-11→ Common Stock (487 underlying)
Exercise/Conversion
Common Stock
2024-08-07$372.46/sh+487$181,388→ 4,691 total
Sale
Common Stock
2024-08-07$1070.00/sh−487$521,090→ 4,204 total

Holdings

Common Stock
(indirect: By 401(k))
10

Footnotes (1)

[F1]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0002009236

Filing Metadata

Form type: 4
Filed: Aug 6, 8:00 PM ET
Accepted: Aug 7, 4:40 PM ET
Size: 8.8 KB

View on SEC.gov